EVFM News

Latest breaking news and updates for EVFM stock.

FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis

-- Evofem now holds eleven Orange Book - listed patents covering SOLOSEC into late 2041 -- SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) today announced that a new...

Will the new patent trigger any competitive responses or licensing disputes that could impact the stock price? What is the expected market size and launch timeline for the SOLOSEC oral granules targeting BV and Trichomoniasis, and how does it compare to existing treatments? How will the extended patent protection for SOLOSEC affect Evofem's revenue projections and valuation?

Patents

6 days ago

Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update

-- Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter -- -- Evofem Advances Plans for Special Meeting of Stockholders to Approve the A&R Merger Agreement and Be...

Are there any contingent or earn‑out provisions in the merger agreement that could affect future financial performance? How might the market’s perception of the merger influence short‑term trading volumes and potential breakout or breakdown patterns? What are the key milestones for product development or commercialization that could drive future revenue growth?

Mergers

11 days ago